(NASDAQ: PRPH)
|
The Quigley Corp. (now ProPhase Labs, Inc.) Profile
|
|
The Quigley Corporation develops and markets diversified healthcare products. For nearly a decade, the Company has been developing, manufacturing, and marketing its proprietary Cold-Eeze® family of patented zinc gluconate glycine (ZIGG) cold-remedy lozenge products. It has also developed a variety of product extensions, which include Cold-Eeze® Sugar Free Tablets, Cold-Eeze® Lozenge Honey Lemon Flavor, Cold-Eeze® Green Tea with Honey, Cold-Eeze® Bubble Gum, and Cold-Eeze® Spearmint Gum. The Company has also launched Kidz-Eeze Sore Throat Pops. In January of 2001, the Company established an ethical pharmaceutical segment, Quigley Pharma, to diversify by gaining entry into the prescription drug market, and ensure safe and effective distribution of any potential new products. Quigley Pharma addresses medical conditions that may be overlooked by large capitalization pharmaceutical companies. Prior to the creation of Quigley Pharma, the Company founded Darius International Inc., which specializes in introducing proprietary products (specifically health and wellness products) into the marketplace through a network of independent representatives.
|
|
